IL6 and metabolic dysfunction-associated steatotic liver disease: An investigation of the potential correlation between the severity of fatty liver disease and changes in the secretion patterns of IL-6 trans-signaling co-receptors in NAFLD linked with diabetes was the focus of separate research.